Yousif Capital Management’s Sarepta Therapeutics SRPT Stock Holding History

Yousif Capital Management’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$461K	Buy	25,642 +153	+0.6%	+$2.89K	0.01%	1377
2026 Q1	$555K	Sell	25,489 -215	-0.8%	-$4.16K	0.01%	1355
2025 Q4	$541K	Buy	25,704 +481	+2%	+$10.1K	0.01%	1383
2025 Q3	$486K	Sell	25,223 -4,018	-14%	-$71.6K	0.01%	1449
2025 Q2	$500K	Buy	29,241 +458	+2%	+$19.5K	0.01%	1456
2025 Q1	$1.84M	Sell	28,783 -817	-3%	-$86K	0.02%	763
2024 Q4	$3.6M	Sell	29,600 -1,239	-4%	-$152K	0.04%	426
2024 Q3	$3.85M	Sell	30,839 -4,558	-13%	-$630K	0.04%	423
2024 Q2	$5.59M	Buy	+35,397	New	+$4.55M	0.06%	288

Other funds holding SRPT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Yousif Capital Management's SRPT Position: Q2 2026 in Review

Yousif Capital Management increased its Sarepta Therapeutics (SRPT) stake by 0.6% in Q2 2026, buying an estimated $2.89K and bringing the position to 25,642 shares worth $461K. The position accounts for 0.01% of the portfolio, ranked #1377.

Yousif Capital Management first reported a position in SRPT in Q2 2024 and has held it in 9 quarters since. The position peaked at $5.59M in Q2 2024. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

Yousif Capital Management held 25,642 shares of Sarepta Therapeutics worth $461K as of Q2 2026.
Yousif Capital Management bought 153 Sarepta Therapeutics shares in Q2 2026, an estimated $2.89K.
Sarepta Therapeutics made up 0.01% of Yousif Capital Management's portfolio in Q2 2026, its #1377 holding.
Yousif Capital Management first reported a position in Sarepta Therapeutics in Q2 2024 and has held it in 9 quarters since.
Yousif Capital Management's Sarepta Therapeutics position peaked at $5.59M in Q2 2024.
323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Yousif Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.